A detailed history of Savant Capital, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Savant Capital, LLC holds 4,027 shares of PEN stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,027
Previous 4,612 12.68%
Holding current value
$1.12 Million
Previous $1.18 Million 13.78%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$227.15 - $287.09 $132,882 - $167,947
-585 Reduced 12.68%
4,027 $1.02 Million
Q2 2025

Aug 06, 2025

SELL
$253.22 - $299.78 $46,086 - $54,559
-182 Reduced 3.8%
4,612 $1.18 Million
Q1 2025

May 08, 2025

BUY
$237.28 - $303.76 $430,188 - $550,716
1,813 Added 60.82%
4,794 $1.28 Million
Q4 2024

Jan 28, 2025

BUY
$190.97 - $253.66 $42,204 - $56,058
221 Added 8.01%
2,981 $707,000
Q3 2024

Nov 04, 2024

BUY
$163.64 - $210.12 $451,646 - $579,931
2,760 New
2,760 $535,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $10.6B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.